• SENSEX 74,294.96
    -19.63 (--0.03%)
  • BANKNIFTY 56,358.70
    302.95 (+0.54%)
Back

Corporate News

Nectar Lifesciences schedules board meeting to review quarterly financial results
10-Aug-2026, 09:51
Nectar Lifesciences Ltd. will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, according to a regulatory filing.